Evaluation of low serum vitamin B12 in the non-anaemic pregnant patient

J. Pardo1,3, Y. Peled1, J. Bar1, M. Hod1, B.A. Sela2, Z.Ben Rafael1 and R. Orvieto1

1 Department of Obstetrics and Gynecology, Rabin Medical Center, Beilinson Campus, Petah Tiqva, and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, and 2 Institute of Chemical Pathology, Sheba Medical Center, Tel Hashomer, Israel


    Abstract
 Top
 Abstract
 Introduction
 Materials and methods
 Results
 Discussion
 References
 
Low serum vitamin B12 concentrations in pregnancy may not indicate true megaloblastic anaemia. In the present study we compared biochemical indices of vitamin B12 deficiency (serum homocysteine and urine methylmalonic acid) in non-anaemic pregnant women with and without low serum vitamin B12 concentrations. The groups were matched for age, parity and gestational age. No differences were found, and all values were within normal range. These results suggest that the measurement of low serum B12 concentrations in pregnant women should be followed by analysis at the biochemical level before vitamin B12 injections are started.

Key words: homocysteine/methylmalonic acid/pregnancy/vitamin B12


    Introduction
 Top
 Abstract
 Introduction
 Materials and methods
 Results
 Discussion
 References
 
Anaemia is a common complication of pregnancy, with an incidence of 20–80%, depending largely on socio-economic status (Puolakka et al., 1980Go). The vast majority of affected women have iron deficiency; more rarely, anaemia during pregnancy is due to a deficiency in vitamin B12. Suspected anaemia, especially of the macrocytic type, is confirmed by measurement of serum folate and vitamin B12 concentrations. However, several studies have shown that up to 20% of normal pregnancies are associated with lower than normal serum vitamin B12 concentrations (Ball and Giles, 1964Go), which increase to normal within hours after delivery (Mollin et al., 1976Go).

Vitamin B12 and folic acid catalyse the remethylation of homocysteine (Hcy) to methionine. Hyperhomocysteinaemia may be caused by a deficiency of cobalamin or folate metabolites. Nutrition also plays a significant role: a diet rich in fresh vegetables and fruits as well as vitamin supplementation has been associated with lower Hcy concentrations (Miner et al., 1996Go). Furthermore, studies have shown that methylmalonyl-CoA, a metabolite of various amino acids, accumulates when its mutase is blocked by deficiencies of its vitamin B12 co-factors or in the presence of congenital abnormalities of the mutase (Cox and White, 1962Go).

The measurement of serum concentrations of methylmalonic acid (MMA) and Hcy metabolites related to vitamin B12 deficiency was introduced in 1990 to establish vitamin B12 deficiency at the biochemical level (Allen et al., 1990Go). Using a combination of serum metabolite concentrations, serum vitamin concentrations, clinical characteristics, and the response to therapy, it has been demonstrated that every vitamin B12-deficient patient who will respond to therapy has an elevation of MMA and/or Hcy, whereas findings of normal concentrations of both metabolites rule out clinical vitamin B12 deficiency (Stabler et al., 1996Go). In line with these findings, Metz et al. suggested that the drop in vitamin B12 serum concentration in pregnancy does not reflect B12 deficiency at the biochemical concentration, and that to establish true B12 deficiency in pregnancy, the concentration of serum Hcy (but not MMA) should be used (Metz et al., 1995Go).

The aim of the present study was to assess vitamin B12 concentrations in normal pregnant women and to examine whether low vitamin B12 concentrations are associated with changes in the biochemical indices of vitamin B12 deficiency, erythrocyte count or erythrocyte morphological indices, as reflected by erythrocyte mean corpuscular volume (MCV).


    Materials and methods
 Top
 Abstract
 Introduction
 Materials and methods
 Results
 Discussion
 References
 
The study population included 147 patients attending the ambulatory High Risk Pregnancy Clinic of Rabin Medical Center, Israel who met the following criteria: (i) pregnancy duration 20–30 weeks; (ii) normal diet; (iii) singleton pregnancy; (iv) no history of anaemia before the present pregnancy; (v) no evidence of malabsorption. Patients with diseases known to cause anaemia (renal disease, thalassaemia, etc.) or maintaining a vegetarian diet were excluded.

All study participants underwent a complete blood count and serum B12 determination. Those with low B12 concentrations (<=100 pmol/l) were designated the study group and compared for plasma Hcy and urine MMA concentrations with an equal number of subjects with normal serum B12 concentrations (>100 pmol/l) matched for age, parity and gestational age (control group).

Hcy was measured in plasma samples that were separated from erythrocytes shortly after blood was drawn. Plasma was reduced by sodium borohydride, followed by treatment with the fluorescent probe monobromobimane. Separation of Hcy by HPLC column and fluorescent detection was performed as previously described (Ueland et al., 1993Go). Urine analysis for MMA was performed by thin-layer chromatography on silica gel G plate, followed by chromatography in amyl acetate–glacial acetic acid H2O and Fast Blue B reagent. Further assessment of MMA concentrations was achieved by capillary gas chromatography-mass spectrometry (Stabler et al., 1986Go).

Normal values for plasma Hcy and urine MMA concentrations are 4–11 µmol/l and <9 mg/g creatinine respectively. Values are presented as mean ±SD. The study groups were compared with Student's t-test; P-values less than 0.05 were considered significant.


    Results
 Top
 Abstract
 Introduction
 Materials and methods
 Results
 Discussion
 References
 
A below-normal value of serum B12 was found in 32 of the 147 patients tested (study group). The results for the study and control groups are shown in Table IGo. No significant between-group difference was noted for mean haemoglobin and mean corpuscular volume (MCV) on complete blood count. There were no cases of MCV >100 fl in either group. Serum Hcy and urine MMA were also comparable between the two groups, and were within normal range.


View this table:
[in this window]
[in a new window]
 
Table I. Patient characteristics and laboratory results
 

    Discussion
 Top
 Abstract
 Introduction
 Materials and methods
 Results
 Discussion
 References
 
Decreased haemoglobin concentration is a frequent finding in pregnancy, but it seldom mandates a full laboratory evaluation, as iron and folic acid supplementation are usually sufficient to avoid anaemia. Furthermore, the diagnosis of specific anaemic deficiencies by laboratory methods is more complicated during pregnancy, because pregnancy may alter `normal' values. Accordingly, the decrease in serum B12 concentrations noted by several studies during pregnancy does not reflect a true tissue depletion of B12 (megaloblastic anaemia) (Ball and Giles, 1964Go). In a recent comparison of 50 pregnant patients with low serum B12 concentrations and 25 pregnant patients with normal concentrations (Metz et al., 1995Go), no significant difference in either serum MMA or total Hcy was reported between the groups. These findings are supported by the present study. Of our 147 randomly selected pregnant patients, 21.7% had low serum B12 concentrations, a rate comparable to the 20% reported (Ball and Giles, 1964Go), but none of them had biochemical indices of B12 deficiency.

Vitamin B12 deficiency may be associated with various pregnancy complications. A derangement of methionine-Hcy metabolism has been noted in ~20% of cases of neural tube defects and recurrent spontaneous abortion (Eskes et al., 1996Go). However, in a later study (Sutterlin et al., 1997Go), no alteration could be demonstrated in serum folic acid and vitamin B12 concentrations in women with unexplained recurrent spontaneous abortions. Pre-eclampsia may also be related to high plasma Hcy concentrations (Laivuori et al., 1999Go), with a direct relationship between the increase in Hcy and the severity of the pre-eclampsia. In the same study, though vitamin B12 concentrations were found to be reduced in pre-eclampsia, there was no correlation between plasma Hcy and vitamin B12. Finally, vitamin B12 apparently plays an important role in the metabolism of the nervous system (Healton et al., 1995Go). Using cranial magnetic resonance imaging, a retardation of myelination in a child's nervous system due to maternal dietary vitamin B12 deficiency has been demonstrated (Lovblad et al., 1997Go).

The usual means for delineating vitamin B12 malabsorption secondary to intrinsic factor deficiency versus other malabsorption factors (Schilling test) is contraindicated in pregnancy because of the risk of radiation exposure. Therefore, therapy is usually instituted empirically in pregnant patients with low serum vitamin B12, and diagnostic testing is delayed until the postpartum period (Campbell, 1995Go). This practice, however, may lead to overtreatment of pregnant patients without true vitamin B12 deficiency. Our results, together with others (Metz et al., 1995Go), suggest that serum Hcy and urine MMA be measured in every pregnant patient with low serum vitamin B12 before treatment with vitamin B12 injections is instituted.

In conclusion, routine serum B12 testing is unnecessary in pregnancy. However, if low serum vitamin B12 is demonstrated, for example, in cases of anaemia refractory to iron and folic acid treatment, it should be followed by MMA and Hcy evaluation.


    Acknowledgments
 
The authors wish to thank Mrs Gloria Ginzach and Mrs Marian Propp for their editorial and secretarial assistance.


    Notes
 
3 To whom correspondence should be addressed at: Department of Obstetrics and Gynecology, Rabin Medical Center (Beilinson Campus), Petah Tiqva 49100, Israel Back


    References
 Top
 Abstract
 Introduction
 Materials and methods
 Results
 Discussion
 References
 
Allen, R.H., Stabler, S.P., Savage, D.G. et al. (1990) Diagnosis of cobalamin deficiency. I. Usefulness of serum methylmalonic acid and total homocysteine concentrations. Am. J. Hematol., 34, 90–98.[ISI][Medline]

Ball, E.W. and Giles, C. (1964) Folic acid and vitamin B12 levels in pregnancy and their relation to megaloblastic anemia. J. Clin. Pathol., 17, 165–174.[ISI]

Campbell, B.A. (1995) Megaloblastic anemia in pregnancy. Clin. Obstet. Gynecol., 38, 455–462.[ISI][Medline]

Cox, E.M. and White, A.M. (1962) Methylmalonic acid excretion: an index of vitamin B12 deficiency. Lancet, ii, 853–856.

Eskes, T.K.A.B., Nelen W.K.D.M., van der Molen, E.F. et al. (1996) Reproductive failure and hyperhomocysteinaemia – the role of folic acid. J. Fertil. Res., 10, 14–17.

Healton, E.B., Savage, D.G., Brust, J.L.M. et al. (1995) Neurologic aspects of cobalamin deficiency. Medicine, 70, 229–245, Baltimore.

Laivuori, H., Kaaja, R., Turpeinen, U. et al. (1999) Plasma homocysteine levels elevated and inversely related to insulin sensitivity in preeclampsia. Obstet. Gynecol., 93, 489–493.[Abstract/Free Full Text]

Lovblad, K., Ramelli, G., Remonda, L. et al. (1997) Retardation of myelination due to dietary vitamin B12 deficiency: cranial MRI findings. Pediatr. Radiol., 27, 155–158.[ISI][Medline]

Miner, S., Evrovski, J. and Cole, D. (1996) Clinical chemistry and molecular biology of homocysteine metabolism: an update. Clin. Biochem., 30, 189–201.[ISI]

Mollin, D.L., Anderson, B.B. and Burman, J.F. (1976) The serum vitamin B12 level: its assay and significance. Clin. Haematol., 5, 521–546.[ISI][Medline]

Metz, S., McGrath, K., Bennett, M. et al. (1995) Biochemical indices of vitamin B12 nutrition in pregnant patients with subnormal serum vitamin B12 levels. Am. J. Hematol., 48, 251–255.[ISI][Medline]

Puolakka, J., Janne, O., Pakarinen, A. et al. (1980) Serum ferritin in the diagnosis of anemia during pregnancy. Acta Obstet. Gynecol. Scand. (Suppl), 95, 57–65.

Stabler, S.P., Marcell, P.D., Podell, E.V. et al. (1986) Assay of methylmalonic acid in the serum of patients with cobalamin deficiency using capillary gas chromatography-mass spectrometry. J. Clin. Invest., 77, 1606–1612.[ISI][Medline]

Stabler, S.P., Lindenbaum, J. and Allen, R.H. (1996) The use of homocysteine and other metabolites in the specific diagnosis of vitamin B12 deficiency. J. Nutr., 126, 1266S–1272S.[Medline]

Sutterlin, M., Bussen, S., Ruppert, D. and Steck, T. (1997) Serum levels of folate and cobalamin in women with recurrent spontaneous abortion. Hum. Reprod., 12, 2292–2296.[Abstract]

Ueland, P.M., Refsumc, H., Stabler, S.P. et al. (1993) Total homocysteine in plasma or serum: Methods and clinical applications. Clin. Chem., 39, 1764–1779.[Abstract/Free Full Text]

Submitted on June 15, 1999; accepted on September 17, 1999.